Bristol Myers Squibb expands grants as Bristol Myers Squibb stock costs EUR 54.42
Published on 10/03/2026 at 11:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On October 1, 2026, Bristol Myers Squibb announced the expansion of its Champions in Care initiative through a company release. Separately, Bristol Myers Squibb stock was quoted at EUR 54.42 by Lang & Schwarz at 11:48 a.m. CEST on October 3, 2026.
Weekend trading at Lang & Schwarz
Lang & Schwarz quoted the stock at EUR 54.42 in weekend trading at 11:48 a.m. CEST on October 3, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Bristol Myers Squibb stock.
Champions in Care expands
The initiative, which began in 2025, will award USD 1 million in grants to nonprofit organizations supporting medically underserved communities across the United States. Bristol Myers Squibb said nominations are due by November 30, 2026, and that nomination does not guarantee funding. The company said nominees may be invited to apply and will be considered through a separate review and selection process. Further details are provided in the Bristol Myers Squibb release.
Next Xetra session
Bristol Myers Squibb has scheduled its third-quarter 2026 results for October 29, 2026. The company said executives will review the results during a conference call beginning at 8:00 a.m. ET, according to its September 18, 2026 announcement. The next Xetra session is scheduled for October 5, 2026.
